BioXcel Therapeutics (BTAI) Earnings Date, Estimates & Call Transcripts

$2.09
-0.22 (-9.52%)
(As of 05/10/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(May. 9)
-$0.87 Missed By -$0.19
Consensus EPS
(May. 9)
-$0.68
Skip Charts & View Estimated and Actual Earnings Data

BTAI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BTAI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioXcel Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.69)($0.69)($0.69)
Q2 20241($0.63)($0.63)($0.63)
Q3 20241($0.59)($0.59)($0.59)
Q4 20241($0.54)($0.54)($0.54)
FY 20244($2.45)($2.45)($2.45)
Q1 20251($0.51)($0.51)($0.51)
Q2 20251($0.42)($0.42)($0.42)
Q3 20251($0.38)($0.38)($0.38)
Q4 20251($0.31)($0.31)($0.31)
FY 20254($1.62)($1.62)($1.62)

BTAI Earnings Date and Information

BioXcel Therapeutics last issued its quarterly earnings data on May 9th, 2024. The reported ($0.87) EPS for the quarter, missing analysts' consensus estimates of ($0.68) by $0.19. The business earned $0.58 million during the quarter, compared to analysts' expectations of $0.42 million. BioXcel Therapeutics has generated ($5.18) earnings per share over the last year (($5.18) diluted earnings per share). Earnings for BioXcel Therapeutics are expected to grow in the coming year, from ($2.46) to ($1.85) per share. BioXcel Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.

BioXcel Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2024
Estimated)
------- 
5/9/2024Q1 2024($0.68)($0.87)($0.19)($0.87)$0.42 million$0.58 million    
3/12/2024Q4 2023($0.98)($0.76)+$0.22($0.76)$1.17 million$0.38 million
11/14/2023Q3 2023($1.29)($1.72)($0.43)($1.72)$0.84 million$0.34 million
8/14/2023Q2 2023($1.72)($1.83)($0.11)($1.83)$0.42 million$0.46 million    
5/8/2023Q1 2023($1.56)($1.84)($0.28)($1.84)$0.50 million$0.21 million    
3/9/2023Q4 2022($1.49)($1.95)($0.46)($1.95)$1.08 million$0.24 million    
11/10/2022Q3 2022($1.34)($1.49)($0.15)($1.49)$3.05 million$0.14 million
8/9/2022Q2 2022($1.20)($1.35)($0.15)($1.35)--    
5/9/2022Q1 2022($1.21)($1.12)+$0.09($1.12)--    
3/10/2022Q4 2021($1.18)($0.93)+$0.25($0.93)--    
11/9/2021Q3 2021($1.08)($0.96)+$0.12($0.96)--    
8/9/2021Q2 2021($1.03)($1.11)($0.08)($1.11)--    

BioXcel Therapeutics Earnings - Frequently Asked Questions

When is BioXcel Therapeutics's earnings date?

BioXcel Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on BTAI's earnings history.

Did BioXcel Therapeutics beat their earnings estimates last quarter?

In the previous quarter, BioXcel Therapeutics (NASDAQ:BTAI) missed the analysts' consensus estimate of ($0.68) by $0.19 with a reported earnings per share (EPS) of ($0.87). Learn more on analysts' earnings estimate vs. BTAI's actual earnings.

How can I listen to BioXcel Therapeutics's earnings conference call?

The conference call for BioXcel Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read BioXcel Therapeutics's conference call transcript?

The conference call transcript for BioXcel Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does BioXcel Therapeutics generate each year?

BioXcel Therapeutics (NASDAQ:BTAI) has a recorded annual revenue of $1.38 million.

How much profit does BioXcel Therapeutics generate each year?

BioXcel Therapeutics (NASDAQ:BTAI) has a recorded net income of -$179.05 million. BTAI has generated -$5.18 earnings per share over the last four quarters.

What is BioXcel Therapeutics's EPS forecast for next year?

BioXcel Therapeutics's earnings are expected to grow from ($2.46) per share to ($1.85) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BTAI) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners